Axacon achieved a satisfactory result for 2010 on the top line as well as on the bottom line. The annual accounts for 2010 show a 23% growth in the gross result, an EBITA of 3,6 million kroner and an after-taxes bottom line of 1,3 million kroner.
"2010 was the year where our focus on Pharma, public health care, 3PL, and larger business groups really started to pay off," CEO Thomas Arne Sørensen |
says. "We are optimistic with regard to the future, and we have launched some exciting strategic initiatives that we expect a lot from. I would like to thank all of our customers, business partners, and dedicated and hardworking employees, who have all supported Axacon in 2010," he finishes. |